NIH Scientists See Therapeutic Potential Against Bacteria, Viruses
National Institutes of Health researchers have identified a naturally occurring lipid—a waxy, fatty acid—used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, they also may have found a potent inflammation therapy against bacterial and viral diseases.
Lipids are known to help Francisella tularensis bacteria, the cause of tularemia, to suppress host inflammation when infecting mouse and human cells. In a new study published in the Journal of Innate Immunity, researchers from NIH’s National Institute of Allergy and Infectious Diseases found a form of the lipid phosphatidylethanoloamine, or PE, present in the bacterium. The composition of PE found in F. tularensis differs from PE found in other bacteria. In cell-culture experiments, the researchers discovered that the natural and a synthetic form of PE reduced inflammation caused by both tularemia bacteria and dengue fever virus.
Tularemia is a life-threatening disease spread to humans via contact with an infected animal or through the bite of a mosquito, tick or deer fly. Although tularemia can be successfully treated with antibiotics, it is difficult to diagnose, mainly because F. tularensis bacteria can suppress the human immune response. Dengue fever, primarily spread by Aedes aegypti mosquitoes, is rarely fatal but usually leads to a high fever, severe headache and pain throughout the body. There is no specific treatment for dengue fever.
After identifying PE as the lipid that impaired the immune response, the scientists began to consider its potential therapeutic value. Because natural F. tularensis is highly infectious and therefore challenging to work with, the group developed synthetic lipids—PE2410 and PEPC2410—that would be much easier to study and produce. They then verified that both synthetic lipids also suppressed the immune response during infection of mouse and human cells in the laboratory.
Because several types of viral infections involve an unconstrained inflammatory response, the group tested natural and their synthetic PE in the laboratory against dengue fever virus-infected human cells. Both versions inhibited the immune response compared to the immune response seen in infected but untreated cells.
The group plans to continue exploring how F. tularensis impairs the immune response. They hope their findings will eventually lead to the development of a potent, broad-spectrum anti-inflammatory therapeutic.
Learn more: Natural Lipid Acts as Potent Anti-Inflammatory
The Latest on: Inflammation therapy
via Google News
The Latest on: Inflammation therapy
- Thinking About Laser or Light Therapy for Rosacea? Here’s How It Workson January 13, 2021 at 8:04 am
Laser therapy is emerging as one of the most effective rosacea treatments. Here, experts share how laser and light therapy works, types, and side effects, depending on your rosacea. The post Thinking ...
- Jessica Simpson uses red light therapy on her boobson January 13, 2021 at 1:21 am
Jessica Simpson uses her anti-inflammatory red light therapy device on her boobs. The 40-year-old star does the at-home treatment all over her body to help with her eczema, which she previously ...
- Men with Prostate Cancer Experience Higher Levels of Fatigue Due to Inflammationon January 12, 2021 at 4:19 pm
Men who are receiving androgen deprivation therapy treatment for prostate cancer experience higher levels of fatigue and depression when compared to men who are not receiving treatment and who have no ...
- 10 Best Turmeric Supplements to Treat Inflammation, Arthritis, Fatigue and Moreon January 9, 2021 at 5:00 am
Turmeric is one of the best dietary supplements used to boost immunity and treat inflammation, arthritis, fatigue, and more.
- Novel Anti-fibrotic Therapy for Glaucomaon January 8, 2021 at 5:00 am
A low molecular weight dextran-sulphate could play a key role in treating open angle glaucoma, a neurodegenerative disease that affects over 70 million people worldwide and causes irreversible ...
- Sigyn Therapeutics Reports Results of Pilot Study to Address Inflammatory CytoVesicleson January 6, 2021 at 5:45 am
Threatening Inflammatory ConditionsThat Are Not Addressed with Drug Therapies San Diego, CA - ( NewMediaWire) - January 06, 2021 - Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology ...
- Sigyn Therapeutics™ Reports Results of Pilot Study to Address Inflammatory CytoVesicleson January 6, 2021 at 5:32 am
Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company whose focus is the treatment of life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome (the Cytokine ...
- Does Blue Light Therapy for Acne Work?on January 5, 2021 at 9:29 am
Blue light therapy for acne is a treatment that's safe for many people. Here's how to know if it's a good option for you, according to dermatologists. The post Does Blue Light Therapy for Acne Work?
- Global Anti-inflammatory Therapy Market 2020 Segmentation, Statistics, Top Manufacturers, Regional Analysis and Forecast to 2025on January 4, 2021 at 1:57 pm
Jan 04, 2021 (CDN Newswire via Comtex) -- Global Anti-inflammatory Therapy Market Growth (Status and Outlook) 2020-2025 has recently been added ...
via Bing News